Mirae Asset Global ETFs Holdings’s Aldeyra Therapeutics ALDX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.6K	Buy	25,815 +612	+2%	+$2.68K	﹤0.01%	2940
2025 Q4	$131K	Sell	25,203 -295	-1%	-$1.52K	﹤0.01%	2554
2025 Q3	$133K	Sell	25,498 -3,094	-11%	-$16.1K	﹤0.01%	2536
2025 Q2	$110K	Sell	28,592 -1,248	-4%	-$3.23K	﹤0.01%	2569
2025 Q1	$172K	Buy	29,840 +1,248	+4%	+$7.38K	﹤0.01%	2397
2024 Q4	$143K	Buy	28,592 +1,515	+6%	+$7.77K	﹤0.01%	2554
2024 Q3	$146K	Buy	27,077 +2,672	+11%	+$12.7K	﹤0.01%	2530
2024 Q2	$80.8K	Buy	+24,405	New	+$95.6K	﹤0.01%	2648

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ALDX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Aldeyra Therapeutics (ALDX) stake by 2.4% in Q1 2026, buying an estimated $2.68K and bringing the position to 25,815 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2940.

Mirae Asset Global ETFs Holdings first reported a position in ALDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $172K in Q1 2025. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

Mirae Asset Global ETFs Holdings held 25,815 shares of Aldeyra Therapeutics worth $43.6K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 612 Aldeyra Therapeutics shares in Q1 2026, an estimated $2.68K.
Aldeyra Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2940 holding.
Mirae Asset Global ETFs Holdings first reported a position in Aldeyra Therapeutics in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Aldeyra Therapeutics position peaked at $172K in Q1 2025.
126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.